5//SEC Filing
Davis Chaim 5
Accession 0001491519-20-000002
CIK 0000896747other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 12:38 PM ET
Size
18.9 KB
Accession
0001491519-20-000002
Insider Transaction Report
Form 5
Davis Chaim
Director
Transactions
- Award
Common Shares
2018-06-21$0.10/sh+33,784$3,378→ 58,507 total - Purchase
Common Shares
2019-01-23$0.10/sh+500,000$50,000→ 2,449,915 total(indirect: By Revach Fund, LP) - Award
Common Shares
2018-10-15$0.09/sh+35,036$3,153→ 93,543 total - Award
Common Shares
2019-10-10$0.09/sh+37,398$3,366→ 197,349 total - Other
Non-Statutory Stock Option
2013-04-26$0.18/sh+50,000$9,000→ 50,000 totalExercise: $0.18From: 2014-04-26Exp: 2023-04-26→ Common Shares (50,000 underlying) - Other
Non-Statutory Stock Option
2019-06-20$0.07/sh+20,000$1,400→ 20,000 totalExercise: $0.07From: 2020-06-20Exp: 2029-06-20→ Common Shares (20,000 underlying) - Award
Common Shares
2019-01-23$0.08/sh+38,993$3,119→ 132,536 total - Award
Common Shares
2019-06-20$0.07/sh+27,415$1,919→ 159,951 total - Other
Non-Statutory Stock Option
2018-06-21$0.10/sh+20,000$2,000→ 20,000 totalExercise: $0.10From: 2019-06-21Exp: 2028-06-21→ Common Shares (20,000 underlying)
Footnotes (2)
- [F1]Previously reported on Form 4.
- [F2]The common shares are in the name of Revach Fund, LP. The reporting person (Davis) is a managing member of Revach Group, LLC which operates as the general partner for the Revach Fund, LP.
Documents
Issuer
AMERICAN BIO MEDICA CORP
CIK 0000896747
Entity typeother
Related Parties
1- filerCIK 0001491519
Filing Metadata
- Form type
- 5
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 12:38 PM ET
- Size
- 18.9 KB